Allergen Immunotherapy for Asthma: Shots vs. SLIT Tablets

If you have allergic asthma, you probably know the drill: inhalers for quick relief, daily controllers to keep inflammation down, and a constant worry about what might trigger your next attack. But there is another path-one that doesn’t just mask symptoms but actually changes how your immune system reacts to allergens. This is Allergen Immunotherapy (a disease-modifying treatment that desensitizes the immune system through controlled exposure to specific allergens). It’s the only treatment available that addresses the root cause of IgE-mediated allergies rather than just suppressing them.

The big question isn’t whether it works-research confirms it does-but which method fits your life better. Do you want the proven track record of traditional Subcutaneous Immunotherapy (SCIT), commonly known as allergy shots? Or do you prefer the convenience of Sublingual Immunotherapy (SLIT), taken as tablets under the tongue at home? Let’s break down the real differences, the science behind them, and how to decide which one is right for you.

How Allergen Immunotherapy Actually Works

To understand why these treatments work, you need to look at what happens in your body during an allergic reaction. When you’re allergic to something like House Dust Mite (HDM) or grass pollen, your immune system mistakes these harmless substances for threats. It produces antibodies called IgE that trigger inflammation, leading to wheezing, coughing, and shortness of breath.

Allergen immunotherapy flips this script. By exposing you to tiny, gradually increasing amounts of the allergen, you teach your immune system to stop overreacting. Think of it as retraining your body’s defense team so they don’t sound the alarm every time you walk into a dusty room. This process takes time-typically three to five years-but the benefits can last long after you stop treatment. In fact, studies show that patients who complete AIT have significantly lower risks of developing new asthma symptoms later in life compared to those who rely solely on medication.

Allergy Shots (SCIT): The Clinical Standard

Subcutaneous Immunotherapy (SCIT) has been around since 1911, making it the veteran of the two options. Here’s how it works:

• Administration: You receive injections under the skin, usually in your upper arm.
• Schedule: Treatment starts with a "build-up" phase where you get weekly shots for 3-6 months. Once you reach your target dose, you move to a "maintenance" phase with monthly visits.
• Setting: Every shot must be given in a clinic or doctor’s office because of the risk of severe reactions, including anaphylaxis.
• Efficacy: Historically, SCIT has shown slightly higher efficacy for controlling asthma symptoms compared to early SLIT trials. It is highly effective for multiple allergens simultaneously, such as pollen, mold, and animal dander.

The downside? Commitment. Over a three-year course, you’ll likely visit the clinic about 50 times. That means taking time off work, arranging childcare, and dealing with travel logistics. For many people, this logistical burden leads to dropouts before they see the full benefit.

SLIT Tablets: The Home-Based Alternative

Sublingual Immunotherapy (SLIT) offers a different approach. Instead of injections, you place a tablet under your tongue daily. Approved products include ACARIZAX (for house dust mite) and GRAZAX (for grass pollen).

• Administration: Place the tablet under your tongue and let it dissolve for two minutes before swallowing.
• Schedule: Daily use, every day, without fail.
• Setting: After the first dose is supervised by a doctor to check for immediate reactions, you take all subsequent doses at home.
• Efficacy: Recent large-scale studies confirm SLIT is highly effective for perennial mite-driven asthma. One pivotal study showed an 81 μg reduction in daily inhaled corticosteroid (ICS) dose, translating to a 42% relative reduction in steroid use compared to placebo.

The main advantage here is convenience. No clinic visits mean no missed workdays. However, adherence is critical. If you skip days, the treatment loses its effectiveness. Studies suggest SLIT adherence rates are around 75-80%, which is better than SCIT’s 60-65%, but still requires discipline.

Head-to-Head Comparison: Shots vs. Tablets

Who Is a Good Candidate for Immunotherapy?

Not everyone with asthma qualifies for AIT. Your allergist will evaluate several factors before recommending either option:

1. Allergen Identification: You must have confirmed sensitivity to specific allergens via skin prick testing or blood tests (specific IgE). AIT is useless if you don’t know exactly what triggers you.
2. Asthma Severity: AIT is generally recommended for mild to moderate allergic asthma (GINA steps 1-3). If you have severe, uncontrolled asthma (steps 4-5), immunotherapy may not be safe or effective until your condition is stabilized with medication.
3. Age: Children as young as 5 can start SCIT, while SLIT tablets are often approved for ages 4 and up. Early intervention can potentially prevent the progression from rhinitis to asthma.
4. Commitment: Are you willing to stick with a treatment for 3-5 years? Consistency is key to success.

If you have non-allergic asthma (triggered by exercise, cold air, or viruses rather than allergens), AIT won’t help. Similarly, if you have certain autoimmune conditions or are taking beta-blockers, you may not be eligible due to increased risks during potential reactions.

Real-World Effectiveness and Long-Term Benefits

Older studies sometimes suggested SCIT was superior for asthma control. However, recent real-world data paints a more nuanced picture. A massive propensity-matched study involving over 14,000 patients found that both forms of AIT led to significant reductions in asthma medication use over nine years. Specifically, patients on SLIT saw a 20% decrease in lower respiratory tract infections requiring antibiotics after stopping treatment.

One of the most compelling benefits of AIT is its disease-modifying nature. Unlike inhalers, which stop working once you stop using them, AIT can provide lasting relief. Research indicates that nine out of ten studies show significantly lower asthma risk in AIT recipients compared to controls. This means fewer exacerbations, less reliance on steroids, and potentially avoiding the development of chronic lung issues.

Cost and Insurance Considerations

Money matters when choosing a treatment. While both SCIT and SLIT are expensive upfront, they may save money in the long run by reducing medication costs and emergency visits.

• SCIT Costs: Include copays for each clinic visit, administration fees, and the cost of the allergen extract. Since you go monthly during maintenance, these costs add up but are spread out.
• SLIT Costs: Involve the price of the tablets themselves, which can be high. However, you avoid transportation costs and lost wages from missing work for appointments.
• Insurance Coverage: Most major insurers cover both SCIT and SLIT for diagnosed allergic asthma, but coverage varies widely. Some plans require prior authorization or limit the number of covered years. Always check with your provider and insurer before starting.

In Europe, SLIT adoption is much higher due to broader reimbursement policies and guideline recommendations. In the US, coverage is improving but still lags behind, partly because fewer allergists offer SLIT compared to SCIT.

Managing Side Effects and Safety

No medical treatment is without side effects, but AIT is generally well-tolerated. Knowing what to expect helps reduce anxiety.

For SCIT: Local reactions like redness, swelling, and itching at the injection site are common and usually mild. Systemic reactions (whole-body hives, wheezing) occur in less than 1% of doses but require immediate medical attention, which is why clinic supervision is mandatory.

For SLIT: The most common side effect is oral pruritus (itching in the mouth or throat). This typically resolves within weeks as your body adjusts. Rarely, systemic reactions can occur, especially if you miss doses and then resume at a high frequency. Always follow your doctor’s instructions on managing missed doses.

Making Your Decision

Choosing between shots and tablets comes down to your lifestyle, allergen profile, and personal preference. If you struggle with daily routines but can commit to monthly visits, SCIT might be easier. If you hate needles and want flexibility, SLIT could be ideal. Remember, the best treatment is the one you’ll actually stick with.

Talk to your allergist about your specific triggers. If house dust mite is your main enemy, SLIT tablets are a proven, convenient option. If you react to multiple pollens and molds, SCIT might offer broader protection. Whichever path you choose, you’re taking a step toward controlling your asthma-not just treating it.